Çolak Ayfer, Çuhadar Serap, Gölcük Burcu, Gölcük Yalçin, Özdoğan Öner, Çoker Işil
Department of Clinical Chemistry, Tepecik Training and Research Hospital, İzmir-Turkey.
Anadolu Kardiyol Derg. 2014 Sep;14(6):519-24. doi: 10.5152/akd.2014.4944.
Preexisting renal failure diminishes the excretion of N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP), therefore limits the diagnostic value of this peptide for concomitant heart failure. The aim of this study was to evaluate the association between NT-proBNP and the stages of renal dysfunction in a typical population attended to emergency department with acute dyspnea.
In this cross-sectional study, all consecutive patients with acute dyspnea underwent clinical evaluation, laboratory assessment of NT-proBNP, and echocardiographic examinations. Among subjects, 54.5% were diagnosed as heart failure. Grouping variables according to renal function capacity and ejection fraction, independent variables were compared with Kruskal-Wallis or ANOVA with posthoc tests. Correlation and linear regression analysis were done to analyze the variables associated with NT-proBNP. The diagnostic performance of NT-proBNP was evaluated by receiver-operating characteristic (ROC) curve.
Serum median NT-proBNP level in patients with severe renal impairment was significantly higher than moderate and mildly decreased renal functions (p=0.001). In patients with moderate and severe left ventricular failure, NT-proBNP was significantly higher compared with normal subjects (LVEF>50%) (p=0.040, and 0.017, respectively). Renal dysfunction was associated in 56% of patients with heart failure. The area under the ROC curve of NT-proBNP for identifying left ventricular failure in patients with renal failure (eGFR<90 mL/min/1.73 m2) was 0.649 and reached significant difference (95% CI:0.548-0.749, p=0.005).
In addition to NT-proBNP measurement in clinical judgement of heart failure, renal functions have to be taken into consideration to avoid misdiagnosis.
既往存在的肾衰竭会减少N端前脑钠肽(NT-proBNP)的排泄,因此限制了该肽对合并心力衰竭的诊断价值。本研究的目的是评估在因急性呼吸困难就诊于急诊科的典型人群中,NT-proBNP与肾功能不全分期之间的关联。
在这项横断面研究中,所有连续的急性呼吸困难患者均接受了临床评估、NT-proBNP的实验室检测以及超声心动图检查。在研究对象中,54.5%被诊断为心力衰竭。根据肾功能和射血分数对变量进行分组,使用Kruskal-Wallis检验或方差分析及事后检验对自变量进行比较。进行相关性和线性回归分析以分析与NT-proBNP相关的变量。通过受试者操作特征(ROC)曲线评估NT-proBNP的诊断性能。
重度肾功能损害患者的血清NT-proBNP中位数水平显著高于中度和轻度肾功能减退患者(p = 0.001)。在中度和重度左心室衰竭患者中,NT-proBNP显著高于正常受试者(左心室射血分数>50%)(分别为p = 0.040和0.017)。56%的心力衰竭患者存在肾功能不全。NT-proBNP用于识别肾衰竭(估算肾小球滤过率<90 mL/min/1.73 m²)患者左心室衰竭的ROC曲线下面积为0.649,差异有统计学意义(95%可信区间:0.548 - 0.749,p = 0.005)。
在心力衰竭的临床判断中,除了检测NT-proBNP外,还必须考虑肾功能,以避免误诊。